Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apricitabine vs Lamivudine in Treatment-experienced HIV-1
NCT00612898Phase 3Terminated
- Sponsor
- Avexa Limited
- Start
- Feb 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of apricitabine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Avexa Limited. Started Feb 2008; status: terminated.
02
Drugs
apricitabine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00612898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00612898.